Not applicableUnknownNCT01927133What this trial is testingLIVER FIBROSIS PREVALENCE IN FRANCEWho this might be right forLiver Fibrosis Progression in Chronic Liver Disease Assistance Publique - Hôpitaux de Paris 10,000
Large-scale testing (Phase 3)Active Not RecruitingNCT04849728What this trial is testingStudy Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )Who this might be right forNASH - Nonalcoholic Steatohepatitis Inventiva Pharma 1,000
Not applicableStudy completedNCT01874249What this trial is testingNon Invasive Assessment of Liver Fibrosis in Fatty Liver DiseaseWho this might be right forNon Alcoholic Fatty Liver Disease Fundación Clínica Médica Sur 1,200
Large-scale testing (Phase 3)Study completedNCT02030977What this trial is testingThe Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic SteatohepatitisWho this might be right forNon Alcoholic Fatty Liver Dr Azita Hekmatdoost 50
Not applicableLooking for participantsNCT03472157What this trial is testingControlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese PatientsWho this might be right forSurgeryObesityNASH - Nonalcoholic Steatohepatitis+1 more University Hospital, Lille 100
Not applicableActive Not RecruitingNCT06315361What this trial is testingDIAbetes and NAFLDWho this might be right forNAFLDDiabetesNASH+3 more Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600
Testing effectiveness (Phase 2)Study completedNCT02217475What this trial is testingEfficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver FibrosisWho this might be right forNonalcoholic Steatohepatitis Tobira Therapeutics, Inc. 289
Testing effectiveness (Phase 2)Study completedNCT00990639What this trial is testingEffect of Candesartan in Alcoholic Liver FibrosisWho this might be right forAlcoholic Liver Disease Yonsei University 85
Not applicableUnknownNCT05220956What this trial is testingImpact of Time-restricted Feeding in NAFLDWho this might be right forFatty Liver DiseaseFatty LiverFatty Liver, Nonalcoholic Johannes Gutenberg University Mainz 100
Large-scale testing (Phase 3)Ended earlyNCT03053050What this trial is testingSafety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) FibrosisWho this might be right forNonalcoholic Steatohepatitis Gilead Sciences 808
Not applicableNot Yet RecruitingNCT07168551What this trial is testingIs There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese PatientsWho this might be right forHyperuricemiaNAFLD (Nonalcoholic Fatty Liver Disease)Liver Fibrosis Assiut University 111
Not applicableLooking for participantsNCT07270601What this trial is testingDevelopment of a Quantifiable Ultrasound Biomarker for Hepatic SteatosisWho this might be right forMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease ContextVision AB 110
Testing effectiveness (Phase 2)Study completedNCT04173065What this trial is testingAssess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASHWho this might be right forNASH - Nonalcoholic Steatohepatitis Viking Therapeutics, Inc. 248
Not applicableUnknownNCT04363424What this trial is testingAlcohol Biomarker StudyWho this might be right forAlcoholic Cirrhosis Maastricht University Medical Center 191
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212What this trial is testingPhase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD SubjectsWho this might be right forMASLD Zhejiang Doer Biologics Co., Ltd. 110
Not applicableLooking for participantsNCT05093881What this trial is testingLong-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 StudyWho this might be right forAlcoholic Cirrhosis Pharmicell Co., Ltd. 100
Not applicableStudy completedNCT02806011What this trial is testingLong-term Follow-up Study of Livercellgram in Alcoholic LC Patients Who Completed Livercellgram Phase 2 StudyWho this might be right forAlcoholic Liver Cirrhosis Pharmicell Co., Ltd. 48
Not applicableWithdrawnNCT01987310What this trial is testingAssessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin TreatmentWho this might be right forNon Alcoholic Fatty Liver Disease Sheba Medical Center
Not applicableUnknownNCT05802199What this trial is testingQuantitative Detection Efficiency of UDFF for Nonalcoholic Fatty Liver DiseaseWho this might be right forNon-alcoholic Fatty Liver Disease Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 300
Not applicableLooking for participantsNCT06814990What this trial is testingAcquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients with Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) PlacementWho this might be right forMASLDLiver Cirrhosis, AlcoholicCirrhosis of Liver+2 more Stephanie Gräger 80